His work is aimed at increasing medical research transparency to make the evidence base more complete, truthful, and reliable. Motivated by his FDA experience, Dr. Turner and co-authors have published articles re-examining the efficacy of various psychotropic drug classes, the best known of these being a paper published a January 2008 article in the New England Journal of Medicine entitled “Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy”.